Research
Hormonal
The use of long‐acting incretin‐based therapies, such as semaglutide, has increased due to their benefits for glycemic control in diabetes, cardiovascular risk reduction, and weight management.
Clinicians should consider the benefits of semaglutide for patients with diabetes and weight management needs.
StrongSupportsmedium confidence
The use of long‐acting incretin‐based therapies, such as semaglutide, has increased in recent years due to their benefits for glycemic control in diabetes, cardiovascular risk reduction, and weight management.
Why this rating
The abstract discusses a review of existing literature.
Source
Legal, safety, and practical considerations of compounded injectable semaglutide
Allison Spitery et al. · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2024
reviewCited 8×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →